NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000256

Registered date:30/09/2005

Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedRenal cell carcinoma
Date of first enrollment2001/08/01
Target sample size540
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Administration of natural type interferon alpha for at least one year Observation

Outcome(s)

Primary OutcomeLocal recurrence and distant metastasis
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteriaActive synchronous malignancy Bellini duct carcinoma von Hippel-Lindau disease History of allergy for interferon or vaccine

Related Information

Contact

public contact
Name Hideyuki Akaza MD
Address Japan
Telephone 029-853-3223
E-mail
Affiliation University of Tsukuba Department of Urology
scientific contact
Name Seiji Nito MD
Address Fukuoka Japan
Telephone
E-mail
Affiliation Kyushu University Department of Urology